FDA Approves NDA Supported By MedAvante Central Ratings
7/31/2012 12:28:19 PM
More...
|
Cipher Pharmaceuticals (DND.TO) Using MedAvante Centralized Ratings in Phase 3 Study
12/7/2010 10:00:58 AM
More...
|
Rexahn Pharmaceuticals, Inc. to Use MedAvante Centralized Ratings in MDD Phase 2b Study
10/26/2010 11:33:51 AM
More...
|
MedAvante Release: FDA Approves NDA That Includes Psychiatric Data Collected by Centralized Raters
9/14/2010 11:15:48 AM
More...
|
MedAvante Opens Moscow Office and Successfully Completes First Centralized Ratings Assessment
5/6/2010 11:32:37 AM
More...
|
MedAvante to Deliver Remote, Expert Patient Assessment in $25 Million, Innovative NIMH Study of Early Schizophrenia Treatment
1/14/2010 8:29:44 AM
More...
|
ICON and MedAvante Sign Alliance Agreement
3/16/2009 11:30:00 AM
More...
|